ATE200025T1 - Flüssige arzneizubereitungen enthaltend schilddrüsenhormone - Google Patents

Flüssige arzneizubereitungen enthaltend schilddrüsenhormone

Info

Publication number
ATE200025T1
ATE200025T1 AT95908224T AT95908224T ATE200025T1 AT E200025 T1 ATE200025 T1 AT E200025T1 AT 95908224 T AT95908224 T AT 95908224T AT 95908224 T AT95908224 T AT 95908224T AT E200025 T1 ATE200025 T1 AT E200025T1
Authority
AT
Austria
Prior art keywords
preparations containing
thyroid hormones
medicinal preparations
liquid medicinal
containing thyroid
Prior art date
Application number
AT95908224T
Other languages
English (en)
Inventor
Jeffrey Dickinson
Karrar Ahmad Khan
John Neville Hague
Alan Smith
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Application granted granted Critical
Publication of ATE200025T1 publication Critical patent/ATE200025T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT95908224T 1994-02-01 1995-01-30 Flüssige arzneizubereitungen enthaltend schilddrüsenhormone ATE200025T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9401891A GB9401891D0 (en) 1994-02-01 1994-02-01 Therapeutic agents
PCT/EP1995/000323 WO1995020955A1 (en) 1994-02-01 1995-01-30 Liquid pharmaceutical compositions comprising thyroid hormones

Publications (1)

Publication Number Publication Date
ATE200025T1 true ATE200025T1 (de) 2001-04-15

Family

ID=10749668

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95908224T ATE200025T1 (de) 1994-02-01 1995-01-30 Flüssige arzneizubereitungen enthaltend schilddrüsenhormone

Country Status (14)

Country Link
US (3) US6458842B1 (de)
EP (1) EP0742714B1 (de)
AT (1) ATE200025T1 (de)
AU (1) AU1663195A (de)
CA (1) CA2182037A1 (de)
DE (1) DE69520492T2 (de)
DK (1) DK0742714T3 (de)
ES (1) ES2155124T3 (de)
GB (1) GB9401891D0 (de)
GR (1) GR3035706T3 (de)
IL (1) IL112516A0 (de)
PT (1) PT742714E (de)
WO (1) WO1995020955A1 (de)
ZA (1) ZA95743B (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401891D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
US6501188B1 (en) * 1997-07-03 2002-12-31 Micron Technology, Inc. Method for improving a stepper signal in a planarized surface over alignment topography
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
CA2306024C (en) * 1997-10-01 2011-04-26 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US7018654B2 (en) 1999-03-05 2006-03-28 New River Pharmaceuticals Inc. Pharmaceutical composition containing an active agent in an amino acid copolymer structure
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US20020099013A1 (en) * 2000-11-14 2002-07-25 Thomas Piccariello Active agent delivery systems and methods for protecting and administering active agents
US7163918B2 (en) 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US7067148B2 (en) 2001-02-15 2006-06-27 King Pharmaceutical Research & Development, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20070066537A1 (en) * 2002-02-22 2007-03-22 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7169752B2 (en) * 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7375082B2 (en) * 2002-02-22 2008-05-20 Shire Llc Abuse-resistant hydrocodone compounds
US7338939B2 (en) * 2003-09-30 2008-03-04 New River Pharmaceuticals Inc. Abuse-resistant hydrocodone compounds
US20030190350A1 (en) * 2001-10-29 2003-10-09 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
US6645526B2 (en) 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US20030099699A1 (en) 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
US7659253B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
KR20050010756A (ko) * 2002-02-22 2005-01-28 뉴 리버 파마슈티칼스, 인크. 피험자 간 약물 혈청 농도의 변동성을 감소시키기 위한펩티드-약물 접합체의 용도
EP2319540A1 (de) * 2002-02-22 2011-05-11 Shire LLC Pharmazeutische Verbindungen mit verzögerter Freisetzung zur Prävention des Missbrauchs von kontrollierten Substanzen
WO2004041208A2 (en) * 2002-11-05 2004-05-21 New River Pharmaceuticals Inc. Controlled absorption of mixed thyroyd hormone formulations
NZ544162A (en) * 2003-05-29 2008-09-26 Shire Llc Abuse resistant amphetamine compounds
ITRM20030363A1 (it) * 2003-07-24 2005-01-25 Fernando Goglia Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
NZ546226A (en) * 2003-09-30 2009-03-31 Shire Llc Oxycodone conjugates for prevention of overdose or abuse
US8318712B2 (en) 2006-01-06 2012-11-27 Intervet International B.V. Concentrated liquid thyroid hormone composition
JP2009534387A (ja) * 2006-04-19 2009-09-24 ノヴァデル ファーマ インコーポレイテッド 安定な含水アルコール性経口噴霧調剤物および方法
US20080171089A1 (en) * 2006-12-22 2008-07-17 Blondino Frank E Stable anti-nausea oral spray formulations and methods
EP2152247A4 (de) * 2007-05-10 2012-12-26 Novadel Pharma Inc Zusammensetzungen und verfahren gegen schlaflosigkeit
US7985325B2 (en) * 2007-10-30 2011-07-26 Novellus Systems, Inc. Closed contact electroplating cup assembly
HUE028423T2 (en) 2011-03-10 2016-12-28 Emp Pharma Gmbh Process for the preparation of levothyroxine solution
GR1008017B (el) 2012-08-03 2013-10-24 Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων, Σταθερο φαρμακευτικο συστημα (κιτ) για την παρασκευη ποσιμου διαλυματος λεβοθυροξινης ή φαρμακευτικως αποδεκτου αλατος αυτης
US9345772B1 (en) * 2015-02-27 2016-05-24 Nilesh Parikh Liquid levothyroxine formulations
EP3311844A1 (de) 2016-10-18 2018-04-25 Altergon S.A. Hochstabile verpackte lösungen von t4-schilddrüsenhormon
US9782376B1 (en) 2016-12-01 2017-10-10 Fresenius Kabi Usa Llc Levothyroxine liquid formulations
US11241382B2 (en) 2019-03-01 2022-02-08 Altergon Sa Administration regimen of compositions of T4 thyroid hormone with high oral absorption
WO2022221480A1 (en) * 2021-04-15 2022-10-20 Vertice Pharma Llc Stable liquid oral dosage forms of liothyronine
WO2024227895A2 (en) 2023-05-02 2024-11-07 Labomed Pharmaceutical Company S.A. Oral solution comprising liothyronine sodium

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA680863A (en) 1964-02-25 G. Ginger Leonard Compositions containing d-isomers of thyronine
US3157574A (en) 1959-05-01 1964-11-17 Smith Kline French Lab Method of reducing cholesterol levels
US3090724A (en) 1961-01-03 1963-05-21 Baxter Laboratories Inc Method of treating dermatological conditions
DE2126533A1 (de) 1971-05-28 1972-12-14 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur Herstellung pharma zeutischer Zubereitungen
DE2546474A1 (de) * 1975-10-17 1977-04-21 Murray M D Israel Injizierbares pharmazeutisches thyroxinpraeparat und verfahren zu dessen herstellung
GB8501372D0 (en) * 1985-01-18 1985-02-20 Smith Kline French Lab Chemical compounds
CN1011118B (zh) * 1986-06-13 1991-01-09 天津医学院附属医院 治疗白内障的眼药水的制药方法
JPH07116031B2 (ja) * 1986-09-24 1995-12-13 株式会社アドバンス 制癌剤
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
US5158978A (en) * 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
JP2622653B2 (ja) * 1992-12-18 1997-06-18 三洋化成工業株式会社 甲状腺ホルモン水溶液
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
GB9401891D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
US5635209A (en) * 1995-10-31 1997-06-03 Vintage Pharmaceuticals, Inc. Stabilized composition of levothyroxine sodium medication and method for its production

Also Published As

Publication number Publication date
PT742714E (pt) 2001-08-30
US20040266877A1 (en) 2004-12-30
EP0742714A1 (de) 1996-11-20
US20030130351A1 (en) 2003-07-10
ZA95743B (en) 1995-08-01
US6706255B2 (en) 2004-03-16
DK0742714T3 (da) 2001-04-30
IL112516A0 (en) 1995-12-08
GR3035706T3 (en) 2001-07-31
AU1663195A (en) 1995-08-21
GB9401891D0 (en) 1994-03-30
CA2182037A1 (en) 1995-08-10
DE69520492D1 (de) 2001-05-03
US6458842B1 (en) 2002-10-01
EP0742714B1 (de) 2001-03-28
WO1995020955A1 (en) 1995-08-10
ES2155124T3 (es) 2001-05-01
DE69520492T2 (de) 2001-07-12

Similar Documents

Publication Publication Date Title
ATE200025T1 (de) Flüssige arzneizubereitungen enthaltend schilddrüsenhormone
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
GEP20043259B (en) Device for Delivery of Aerosolized Active Agent to the Lung of a Human Patient
DE69738000D1 (de) Neue Arzneiformulierung enthaltend Budesonide
ATE435294T1 (de) Verabreichung von biologisch aktiven polypeptiden
AU2003301190A1 (en) Administration of capsaicinoids
DK0971705T3 (da) Lægemiddelformuleringer til hormonerstatningsterapi til lokal påföring på huden
ATE298561T1 (de) Orale dareichungsform
DE69312916D1 (de) Wirkstoffabgabevorrichtungen
MXPA01007411A (es) Composiciones y metodos para suministro mucoso.
BG103552A (bg) Терапевтични средства
ATE190225T1 (de) Arzneiform zur abgabe von wirkstoffen an wunden
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
DE59808186D1 (de) Transdermales therapeutisches system zur abgabe von hormonen
BR0012082A (pt) Formulação farmacêutica para administração compreendendo morfina e seu uso
NZ320237A (en) Stable pharmaceutical forms of administration containing parathormone
DE60019334D1 (de) Antivirale arznei
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
FI972004A7 (fi) Implantoitava laite vaikuttavien aineiden antamiseen kasveille
PL348202A1 (en) Pharmaceutically active composition and dispensing device
DK0871467T3 (da) Ny formulering til afgivelse af peptid
MY108692A (en) Topical composition
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee